Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
Cardiovascular and Interventional Radiology|March 20, 2002
Percutaneous removal of a fractured endostent remnant from the portal veinJean-Francois H Geschwind, Mandeep S Dagli, Jens Vogel-Claussen, et al.
Gastroenterology Research and Practice|June 20, 2015
Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in ManagementKelly J Lafaro, David Cosgrove, Jean-Francois H Geschwind, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|April 4, 2019
tRNAs and tRNA fragments as modulators of cardiac and skeletal muscle functionEleni Liapi, Marc van Bilsen, Robin Verjans, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 13, 2002
Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumorsJean-Francois H Geschwind, Shaifali Kaushik, Douglas E Ramsey, et al.
European Radiology|January 19, 2016
Evaluation of 70-150-μm doxorubicin-eluting beads for transcatheter arterial chemoembolization in the rabbit liver VX2 tumour modelAli Gholamrezanezhad, Sahar Mirpour, Jean-Francois H Geschwind, et al.
Targeted Oncology|March 27, 2013
Ultrasound-guided direct delivery of 3-bromopyruvate blocks tumor progression in an orthotopic mouse model of human pancreatic cancerShinichi Ota, Jean-Francois H Geschwind, Manon Buijs, et al.
AJR. American Journal of Roentgenology|June 20, 2008
Chemoembolization of hepatic metastases from ocular melanoma: assessment of response with contrast-enhanced and diffusion-weighted MRIManon Buijs, Josephina A Vossen, Kelvin Hong, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 7, 2007
Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imagingManon Buijs, Ihab R Kamel, Josephina A Vossen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinomaTimothy M Pawlik, Diane K Reyes, David Cosgrove, et al.
Pageof 13